73,615 research outputs found

    Meeting the four-hour deadline in an A&E department

    Get PDF
    This is the print version of the Article. The official published version can be obtained from the link below - Copyright @ 2011 EmeraldPurpose – Accident and emergency (A&E) departments experience a secondary peak in patient length of stay (LoS) at around four hours, caused by the coping strategies used to meet the operational standards imposed by government. The aim of this paper is to build a discrete-event simulation model that captures the coping strategies and more accurately reflects the processes that occur within an A&E department. Design/methodology/approach – A discrete-event simulation (DES) model was used to capture the A&E process at a UK hospital and record the LoS for each patient. Input data on 4,150 arrivals over three one-week periods and staffing levels was obtained from hospital records, while output data were compared with the corresponding records. Expert opinion was used to generate the pathways and model the decision-making processes. Findings – The authors were able to replicate accurately the LoS distribution for the hospital. The model was then applied to a second configuration that had been trialled there; again, the results also reflected the experiences of the hospital. Practical implications – This demonstrates that the coping strategies, such as re-prioritising patients based on current length of time in the department, employed in A&E departments have an impact on LoS of patients and therefore need to be considered when building predictive models if confidence in the results is to be justified. Originality/value – As far as the authors are aware this is the first time that these coping strategies have been included within a simulation model, and therefore the first time that the peak around the four hours has been analysed so accurately using a model

    Selective COX-2 inhibitors and risk of myocardial infarction

    Get PDF
    Selective inhibitors of cyclooxygenase- 2 ( COX- 2, ` coxibs') are highly effective anti-inflammatory and analgesic drugs that exert their action by preventing the formation of prostanoids. Recently some coxibs, which were designed to exploit the advantageous effects of non- steroidal anti-inflammatory drugs while evading their side effects, have been reported to increase the risk of myocardial infarction and atherothrombotic events. This has led to the withdrawal of rofecoxib from global markets, and warnings have been issued by drug authorities about similar events during the use of celecoxib or valdecoxib/ parecoxib, bringing about questions of an inherent atherothrombotic risk of all coxibs and consequences that should be drawn by health care professionals. These questions need to be addressed in light of the known effects of selective inhibition of COX- 2 on the cardiovascular system. Although COX- 2, in contrast to the cyclooxygenase-1 ( COX- 1) isoform, is regarded as an inducible enzyme that only has a role in pathophysiological processes like pain and inflammation, experimental and clinical studies have shown that COX- 2 is constitutively expressed in tissues like the kidney or vascular endothelium, where it executes important physiological functions. COX- 2- dependent formation of prostanoids not only results in the mediation of pain or inflammatory signals but also in the maintenance of vascular integrity. Especially prostacyclin ( PGI(2)), which exerts vasodilatory and antiplatelet properties, is formed to a significant extent by COX- 2, and its levels are reduced to less than half of normal when COX- 2 is inhibited. This review outlines the rationale for the development of selective COX- 2 inhibitors and the pathophysiological consequences of selective inhibition of COX- 2 with special regard to vasoactive prostaglandins. It describes coxibs that are currently available, evaluates the current knowledge on the risk of atherothrombotic events associated with their intake and critically discusses the consequences that should be drawn from these insights. Copyright (C) 2005 S. Karger AG, Basel

    Signatures of non-gaussianity in the isocurvature modes of primordial black hole dark matter

    Get PDF
    Primordial black holes (PBHs) are black holes which may have formed very early on during the radiation dominated era in the early universe. We present here a method by which the large scale perturbations in the density of primordial black holes may be used to place tight constraints on non-gaussianity if PBHs account for dark matter (DM). The presence of local-type non-gaussianity is known to have a significant effect on the abundance of primordial black holes, and modal coupling from the observed CMB scale modes can significantly alter the number density of PBHs that form within different regions of the universe, which appear as DM isocurvature modes. Using the recent \emph{Planck} constraints on isocurvature perturbations, we show that PBHs are excluded as DM candidates for even very small local-type non-gaussianity, fNL0.001|f_{NL}|\approx0.001 and remarkably the constraint on gNLg_{NL} is almost as strong. Even small non-gaussianity is excluded if DM is composed of PBHs. If local non-Gaussianity is ever detected on CMB scales, the constraints on the fraction of the universe collapsing into PBHs (which are massive enough to have not yet evaporated) will become much tighter.Comment: 23 pages, 11 figures. V2: minor corrections and changes, matches published versio
    corecore